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5. Summary
The antiapoptotic Bcl-xL protein plays a key role in the control of apoptosis and in the
pathogenesis of a variety of malignant diseases. The influence of the 5'-noncoding
region of the bcl-x gene and the influence of the 5'–nontranslated region of the bcl-x
mRNA on the expression of the bcl–x gene has been investigated in this work.
Previously unknown parts of the human bcl-x gene were sequenced and the sequence
of the hitherto unidentified complete human bcl-xL mRNA-sequence was determined.
Identification and detection of mono- and bicistronic spliceforms of the bcl-x mRNA
in several human cell lines and mapping of different transcription start sites in the
5'–NCR of the human bcl-x gene helped identify different mechanisms for the control
of bcl-x gene expression.
The position of several transcription start-sites and the location of the major pro-
moter activity in the 5'-noncoding region of the human bcl-x gene support the hy-
pothesis that the selection of certain transcription start sites and transcriptional ac-
tivity are controlled by downstream promoter elements.
Functional analysis revealed that the 5'-nontranslated region of the human bcl-x
mRNA contains an internal ribosome entry site (IRES) which facilitates the transla-
tion of this particular mRNA by a CAP-independent mechanism. These results lead
to the conclusion that the expression of the human bcl–x gene is significantly con-
trolled at the level of translation. This constitutes the first example of an apoptosis
control gene regulated by IRES-mediated initiation of translation.
Transient expression of antisense and anti-antisense RNA which correspond to the
5'–nontranslated region of different bcl-x mRNA forms enabled the identification of
the preferentially translated bcl-x mRNA form. In addition, these experiments show
for the first time that CAP-independent translation of the bcl-x mRNA can be com-
petitively inhibited by the expression of truncated RNAs containing only the transla-
tional control sequences.
A cellular bcl-x antisense RNA that shows no influence on the bcl-x gene expression
was identified and detected in several human cell-lines. The low concentration of this
antisense RNA and the existence of two bicistronic bcl-xL mRNAs support the hy-
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pothesis that the cellular bcl-x antisense mRNA may have a catalytic function in
trans-splicing.
Finally, determining the equilibrium concentration of a protein in a certain tissue or
cell type from the total concentration of its mRNA variants is not acceptable if the
mRNA variants are translated differentially.
